Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-03 | B. Lynne Parshall, Esq. Class III Audit Committee Chair Compensation and Talent Committee member 2018 compensation: $282,104 Director Compensation section |
| 2020-03-26 | B. Lynne Parshall, Esq. 66 Class III Chair Audit Committee 45,000 168,562 213,562 |
| 2021-04-07 | The following table sets forth the names of each member of our Board of Directors, their age, position, director class and committee membership as of April 1, 2021. Director Age Position/Class Audit Committee Compensation and Talent Committee Nominating and Governance Committee Science and Technology Committee B. Lynne Parshall, Esq. 67 Class III Chair |
| 2022-04-08 | The following table sets forth the names of each member of our Board of Directors, their age, position, director class and committee membership as of April 8, 2022. B. Lynne Parshall, Esq. 68 Class III Chair Audit Committee Compensation and Talent Committee Science and Technology Committee ... Director Compensation Table for 2021 Ms. Parshall $71,250 $150,781 $121,600 $343,631 |
| 2023-04-07 | The Audit Committee consists of directors Ms. Parshall (Chair), Dr. Kaye, Dr. Henderson and Mr. Smith. The Compliance Committee consists of directors Ms. Wysenski (Chair), Ms. Bhanji, Mr. Costa, Ms. Parshall, and Mr. Smith. The Nominating and Governance Committee consists of directors Dr. Henderson (Chair), Ms. Bhanji, Mr. Costa, and Ms. Parshall. |
| 2024-04-08 | B. Lynne Parshall, Esq. has served as a member of our Board of Directors since February 2013. She currently serves as a member of the Board of Directors of Ionis Pharmaceuticals, Inc. and Foghorn Therapeutics Inc. Ms. Parshall was employed at Ionis from 1991 to 2017 where she held various positions of increasing responsibility. Prior to joining Ionis, she was a partner at the law firm of Cooley LLP. Ms. Parshall has served on the Board of Directors of Repetoir Immune Medicines, Inc. since December 2021, Ring Therapeutics since March 2022 and Foghorn Therapeutics since August 2022 and each of Alltrna and Celdeara Medical since 2023. Ms. Parshall served as a member of the Board of Directors of Akcea Therapeutics Inc. from 2015 to October 2020. Ms. Parshall is a member of the Licensing Executives Society and a member of the American, California and San Diego bar associations. She holds a J.D. from Stanford Law School and a B.A. from Harvard University. |
Data sourced from SEC filings. Last updated: 2026-03-09